.Pfizer's period 3 Duchenne muscle dystrophy (DMD) gene therapy failure has actually blown a $230 mi...
.After more than 20 years of work with neurodegenerative diseases, Swiss biotech a/c Invulnerable in...
.GSK has actually ditched a phase 2 human papillomavirus (HPV) injection coming from its pipeline af...
.Operating system Therapies will certainly specify on the NYSE American supply substitution this mor...
.ALX Oncology's period 2 stomach cancer cells reaction cost has weakened. After observing its CD47 b...
.Another of Ionis Pharmaceuticals' key midphase readouts has disappointed desires, motivating the bi...
.While Biogen's pharma peers are hunting for late-stage possessions along with little threat, CEO Ch...
.Instil Biography has been a biotech searching for a pipeline after it junked its lead possessions o...
.Biogen has handed back liberties to a very early Alzheimer's illness program to Denali Rehabs, leav...
.Invite to this week's Chutes & Ladders, our roundup of notable management hirings, firings and r...